Medical Developments International Limited Medical Developments International Limited

Medical Developments International Limited

MVP

Rank in Stocks #27223
Medical Developments International Limited (MDIL) specializes in the... Medical Developments International Limited (MDIL) specializes in the development and provision of essential emergency medical solutions, serving global markets including Australia, Europe, and the United States. The company's operations are divided into two primary segments: Pain Management and Respiratory care. Among its key offerings is Penthrox, a product specifically formulated for rapid pain relief in acute trauma and emergency situations. Within the respiratory segment, MDIL supplies equipment designed to assist individuals with conditions like asthma and chronic obstructive pulmonary disease (COPD). Additionally, its comprehensive portfolio features a diverse array of medical devices, encompassing items such as CPR face shields and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, oxygen resuscitation kits, and various oxygen therapy and resuscitation apparatus. Established in 2003, the company maintains its headquarters in Scoresby, Australia.
Share Price
$0.28564034
Market Cap
$32.18M
Change (1 day)
0.00%
Change (1 year)
-10.90%
Country
AU
Trade Medical Developments International Limited (MVP)

Category

Healthcare
Stock price history for Medical Developments International Limited (MVP)
Highest end of day price: $0.30 on 2026-10-01

Lowest end of day price: $6.80 on 2020-01-01
Stock price history of Medical Developments International Limited from 2020 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 12.22%
2025 -2.01%
2024 -32.24%
2023 -73.18%
2022 -53.64%
2021 -11.84%
2020 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$161.15 21.02%
DE
$41.46 47.41%
JP
$212.49 23.19%
CH
$19.19 -0.09%
IN